TMIC-42. LOCAL TISSUE METABOLOMICS BASED BIOMARKERS OF RESPONSE TO THERAPY FOR GLIOBLASTOMA

Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system (CNS), with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant trans...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Rajani, Karishma, Carlstrom, Lucas, Jacobs, Joshua, Schroeder, Mark, Olson, Ian, Wang, Xuewei, Sarkaria, Jann, Burns, Terry
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Tumor Microenvironment
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846014/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados